Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.255 USD | -0.82% | -5.86% | -0.35% |
04-19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
04-05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
Business Summary
Number of employees: 274
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Treatments for Cancer
100.0
%
| 91 | 100.0 % | 100 | 100.0 % | +9.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 91 | 100.0 % | 100 | 100.0 % | +9.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Nick Leschly
CHM | Chairman | 51 | 03/05/21 |
Susan Abu-Absi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 13/02/22 | |
Jenn Snyder
IRO | Public Communications Contact | - | - |
Investor Relations Contact | - | - | |
Teresa Jurgensen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Lynch
BRD | Director/Board Member | 65 | 14/10/21 |
Nick Leschly
CHM | Chairman | 51 | 03/05/21 |
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Denice Torres
BRD | Director/Board Member | 64 | 14/10/21 |
Sarah Glickman
BRD | Director/Board Member | 54 | 14/10/21 |
Wei Lin
BRD | Director/Board Member | 63 | 06/03/23 |
Marcela Maus
BRD | Director/Board Member | 48 | 14/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,311,132 | 50,120,123 ( 97.68 %) | 0 | 97.68 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.35% | 219M | |
+1.51% | 42.75B | |
+48.66% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TSVT Stock
- Company 2seventy bio, Inc.